This interaction suggests that VDD may specifically potentiate obesity-related OSA mechanisms rather than acting as an independent risk factor, with implications including the role of vitamin D in adipose tissue inflammation, metabolic dysfunction, and insulin resistance. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.